Found: 17
Select item for more details and to access through your institution.
Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 642, doi. 10.1111/bjh.15251
- By:
- Publication type:
- Article
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 188, doi. 10.1111/bjh.14146
- By:
- Publication type:
- Article
Clinical features and prognostic factors in solitary plasmacytoma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 554, doi. 10.1111/bjh.13870
- By:
- Publication type:
- Article
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 160, doi. 10.1111/ejh.13086
- By:
- Publication type:
- Article
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 10, p. 2621, doi. 10.1007/s00520-012-1511-y
- By:
- Publication type:
- Article
Management of Multiple Myeloma and Usage of Bortezomib: Perspective from india and Ukraine.
- Published in:
- Frontiers in Oncology, 2016, v. 6, p. 1, doi. 10.3389/fonc.2016.00243
- By:
- Publication type:
- Article
Managing treatment-related peripheral neuropathy in patients with multiple myeloma.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2016, v. 6, p. 37, doi. 10.2147/BLCTT.S91251
- By:
- Publication type:
- Article
Generation of a Quantitative Real Time-Polymerase Chain (Q-PCR) Assay to Identify BCR/ABL1-like ALL Cases.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S5, doi. 10.1016/j.clml.2016.07.008
- By:
- Publication type:
- Article
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 195, doi. 10.1007/s00280-008-0905-5
- By:
- Publication type:
- Article
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 993, doi. 10.1002/ajh.22161
- By:
- Publication type:
- Article
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 5, p. 971, doi. 10.1002/cncr.27820
- By:
- Publication type:
- Article
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5544, doi. 10.1002/cncr.27657
- By:
- Publication type:
- Article
Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: a 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 1, p. 119, doi. 10.1111/j.1365-2141.2010.08380.x
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1162990
- By:
- Publication type:
- Article